A Phase II Study of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer.

Trial Profile

A Phase II Study of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
  • Indications Endometrial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Aug 2013 Planned end date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.
    • 27 Aug 2012 Planned end date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top